Navigation Links
Verenium Corporation to Announce Fourth Quarter and Year-End 2010 Financial Results
Date:2/22/2011

SAN DIEGO, Feb. 22, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that it will release 2010 fourth quarter and year-end financial results on Tuesday, March 1, 2011 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Tuesday, March 1 at 5:00 p.m. ET.

The call may be accessed by dialing 877-755-7422 (domestic) or 678-894-3067 (international) five minutes prior to start time and providing the passcode 39954250.  A link to the live webcast may be accessed by visiting the "Investors" section of the Company's website at http://www.verenium.com.  A replay of the event will be available on the Company's website approximately two hours after the call and will be archived for 30 days.

About Verenium

Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries including the global food and fuel markets.  Read more at www.verenium.com.

Forward-Looking Statements

Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially from those
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium to Present at Jefferies 11th Global Clean Technology Conference
2. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
3. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
4. Verenium Reports Financial Results for the Third Quarter 2010
5. Verenium to Present at Jefferies 10th Global Clean Technology Conference
6. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
7. Verenium Announces Regulatory Approval for Purifine® PLC in China
8. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
9. Verenium Appoints Kevin Bracken Vice President of Manufacturing
10. Verenium Announces Proposed Public Offering of Common Stock
11. Verenium 1:12 Reverse Stock Split Takes Effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015 ... that it has hit a milestone of 4,000 ... was FDA 510(k) cleared in early 2014 as ... in posterolateral spine fusion procedures.  This is a ... as less than 6% of new synthetic products ...
(Date:7/28/2015)... ZIONA, Israel , July ... (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its ... today announced that Shomrat Shurtz has been appointed ... 2015.      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ... 25 years of experience in marketing, regulatory and ...
(Date:7/27/2015)... /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or ... for the treatment of cancer, today provides the following ... closed a $1,000,000 unit offering private placement.  This financing ... the Company at a price of $0.06 per unit.  ... one common share purchase warrant.  Each whole warrant is ...
(Date:7/27/2015)...   Inocucor Technologies Inc ., the agriculture ... farmers, has received a notice of allowance from ... patent application to protect Inocucor consortia and unique ... yields on farms and in greenhouses. ... microbial consortium and its fermentation byproducts, which are ...
Breaking Biology Technology:Revolutionary Bone Graft Exceeds Expectations 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Quest PharmaTech Closes $1,000,000 Private Placement 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 3
... ATHENS, Ga., March 23 ArunA Biomedical, ... Inc. of Edina, MN, giving Neuromics the right ... Human Neural Cells and Neural Culture Medium to ... )ArunA has an exclusive worldwide license to ...
... Horizon Therapeutics, a privately held biopharmaceutical company ... executive officer will present at InsideVenture,s Debut Conference, ... Therapeutics has been selected from over 170 nominations ... showcased to long-term investors through presentations and 1-on-1 ...
... Ohio, March 23 NanoLogix announces that veteran journalist ... in advance of major news. Scanlon,s addition to ... information flow to investors and media, and will aid ... Bill Scanlon brings 25 years of experience in ...
Cached Biology Technology:ArunA Biomedical, Inc. Announces Alliance with Neuromics for Distribution of Normal Human Neural Cells 2Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, California 2Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, California 3NanoLogix Adds Noted Journalist Bill Scanlon to Provide Media Relations 2
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... Lukiw, PhD, Associate Professor of Neuroscience and Ophthalmology ... lead author of a paper identifying, for the first ... acid (RNA), once thought to be no more than ... Alzheimer,s disease. The paper, An NF-kB-sensitive micro RNA-146a-mediated inflammatory ...
... Americans have headed to the polls to elect their next ... Current Biology , a Cell Press publication, reveals how ... time they reach a consensus to go for the more ... stickleback fish preferred to follow larger over smaller leaders," said ...
... CHARLOTTESVILLE, VA (November 13, 2008) In a report now ... the December 2008 issue of the Journal of Urology, ... PhD and his colleagues have confirmed the accuracy and reliability ... for detecting low concentrations of sperm. Herr, a ...
Cached Biology News:LSUHSC research identifies key contributor to Alzheimer's disease process 2Fish choose their leaders by consensus 2Fish choose their leaders by consensus 3First at-home test for vasectomized men proves to be safe, accurate 2
... Methylation-specific PCR (MSP) is a ... abnormal gene methylation utilizing small amounts ... an initial bisulfite reaction to modify ... with specific primers designed to distinguish ...
... The iEMS Incubator/Shaker HT is ... the iEMS Incubator/Shaker HT is ... DNA hybridization and primer extension ... available as a one-cabinet model, ...
... Pseudomonas atlantica Description: Beta-Agarase is useful ... from low-melting-temperature agarose. Beta-Agarase digests the ... User Friendly Properties: Heat Inactivation: 65C, ... Optimum pH: 6.5 Purity: Tested for ...
... modified nucleotide structure called a ?cap? ... most naturally-occurring eukaryotic mRNAs and many ... for a portion of the GTP ... reaction results in the synthesis of ...
Biology Products: